doxazosin has been researched along with Cancer of Cervix in 1 studies
Doxazosin: A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
doxazosin : A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jamal, A | 1 |
| Shahzadi, L | 1 |
| Ahtzaz, S | 1 |
| Zahid, S | 1 |
| Chaudhry, AA | 1 |
| Rehman, IU | 1 |
| Yar, M | 1 |
1 other study available for doxazosin and Cancer of Cervix
| Article | Year |
|---|---|
Identification of anti-cancer potential of doxazocin: Loading into chitosan based biodegradable hydrogels for on-site delivery to treat cervical cancer.
Topics: Cell Cycle; Chitosan; Doxazosin; Drug Liberation; Female; Flow Cytometry; G1 Phase; Humans; Hydrogel | 2018 |